Year: 2016

09
December 2016
Enterome further strengthens its leadership team and Board adding clinical development experience
Read more
16
November 2016
Bristol-Myers Squibb and Enterome SA Announce Immuno-Oncology Collaboration Focused on Microbiome-Derived Biomarkers, Drug Targets and Bioactive Molecules
Read more
19
September 2016
Enterome appoints Christophe Bonny as Chief Scientific Officer
Read more
19
May 2016
Enterome initiates strategic expansion with the opening of US office in Cambridge, MA
Read more
20
April 2016
Enterome raises €14.5 million in Series C financing round Nestlé Health Science invests alongside existing investors
Read more
18
April 2016
Enterome in-licenses novel compounds from Vertex Pharmaceuticals to treat microbiome-related inflammatory bowel diseases
Read more
13
April 2016
Enterome to participate at the FBR Healthcare Series Conference and the Guggenheim Securities Microbiome Day in New York
Read more
07
January 2016
Enterome announces collaboration with Johnson & Johnson Innovation focused on the discovery of novel targets and therapeutics for Crohn’s disease
Read more
06
January 2016
Takeda and Enterome enter strategic drug discovery collaboration focused on Microbiome Targets Across Multiple Gastrointestinal Disorders
Read more

Enterome France

Headquarters
94/96 avenue Ledru-Rollin 75011 Paris – France
Tel: +33 (0)1 75 77 27 85
Lab facilities
Biocluster Genopole
5 rue Henri Desbruères – 91030 Evry Cedex